Researchers from College of Medicine, Department of Urology describe findings in cancer vaccines

Current study results from the report, "Vaccines in renal cell carcinoma," have been published. "Considerable progress in our understanding of the molecular and cellular events that promote growth and progression of renal cell carcinoma (RCC) has dramatically improved the prospects of significantly altering the progression and metastatic potential of renal neoplasms. Cancer vaccination, one form of active specific immunotherapy, represents a promising approach which aims to expand the number of T cells capable of reducing/eradicating the tumor mass, and to induce tumor-specific memory T cells that control tumor recurrence," scientists writing in the journal Seminars In Oncology...

Want to see the full article?

• Purchase this article for only $3.00